Baicalin Plays an Anti-Osteosarcoma Role in Vitro and Promotes Osteogenic Differentiation by Inhibiting NF-κB Signaling.

MLA

Zhao, Zhi-Fei, et al. “Baicalin Plays an Anti-Osteosarcoma Role in Vitro and Promotes Osteogenic Differentiation by Inhibiting NF-ΚB Signaling.” Discovery Medicine, vol. 36, no. 187, Aug. 2024, pp. 1648–56. EBSCOhost, https://doi.org/10.24976/Discov.Med.202436187.151.

APA

Zhao, Z.-F., Cheng, X.-F., Yu, M., Shi, W.-F., & Zhang, T. (2024). Baicalin Plays an Anti-Osteosarcoma Role in Vitro and Promotes Osteogenic Differentiation by Inhibiting NF-κB Signaling. Discovery Medicine, 36(187), 1648–1656. https://doi.org/10.24976/Discov.Med.202436187.151

Chicago

Zhao, Zhi-Fei, Xue-Fei Cheng, Meng Yu, Wen-Fu Shi, and Tao Zhang. 2024. “Baicalin Plays an Anti-Osteosarcoma Role in Vitro and Promotes Osteogenic Differentiation by Inhibiting NF-ΚB Signaling.” Discovery Medicine 36 (187): 1648–56. doi:10.24976/Discov.Med.202436187.151.